|
Volumn 187, Issue 1, 2015, Pages 227-228
|
Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant
a a b c,d d a b b d e |
Author keywords
Heart failure hospitalizations; Heart failure with preserved ejection fraction; Interatrial septal device
|
Indexed keywords
FUROSEMIDE;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEVICE SAFETY;
FOLLOW UP;
HEART FAILURE WITH PRESERVED EJECTION FRACTION;
HEART INDEX;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART VALVE PROSTHESIS;
HOSPITALIZATION;
HUMAN;
LETTER;
NEUROTOXICITY;
NEW YORK HEART ASSOCIATION CLASS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
SCORING SYSTEM;
TREATMENT OUTCOME;
ADVERSE EFFECTS;
CLINICAL TRIAL;
HEART CATHETERIZATION;
HEART FAILURE;
HEART STROKE VOLUME;
HEART SURGERY;
PATHOPHYSIOLOGY;
PROCEDURES;
PROSTHESIS IMPLANTATION;
CARDIAC CATHETERIZATION;
CARDIAC SURGICAL PROCEDURES;
HEART FAILURE;
HUMANS;
PROSPECTIVE STUDIES;
PROSTHESIS IMPLANTATION;
STROKE VOLUME;
TREATMENT OUTCOME;
|
EID: 84929169415
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2015.03.198 Document Type: Article |
Times cited : (33)
|
References (5)
|